Page results
-
UCLH doctor 1 of 10 international members elected to National Academy of Medicine
-
A huge thank you and well done to everyone who ran the London Marathon last weekend to support UCLH.
-
Information for the Camden Sickle Cell and Thalassaemia Service
-
Volunteers are being asked to sign up to the latest Covid-19 vaccine study to begin across the UK including at UCLH.
-
UCLH Biomedical Research Centre supported Consultant Infectious Diseases Physician Professor Sir Alimuddin (Ali) Zumla has been awarded the 2020 Mahathir Science Award, the most prestigious international science award presented in recognition for the best scientific work in solving priority health problems in the tropics.
-
A cancer treatment that is currently available to only a limited number of UK patients is to be tested at UCLH in a countrywide clinical trial to see if it causes fewer long-term side effects than standard radiotherapy.
-
We want to make you aware that our children and young people’s teams will be available throughout the holiday period to provide advice and support when needed.
-
The Digital Innovation Hub will create a safe space for innovators across UCLH, UCL and third-party collaborators to work effectively together to solve problems that add value to patients, staff, UCLH and the wider NHS.
-
A team at UCLH, UCL and Mercedes-AMG High Performance Powertrains which developed a Continuous Positive Airway Pressure (CPAP) breathing aid now used in hospitals across the UK have received an award from the Royal Academy of Engineering for exceptional services during a pandemic.
-
A minimally invasive technique for treating prostate cancer has been used for the first time in the NHS at UCLH. It can be used with precision to treat the affected area, reducing side effects.
File results
-
FOI/2023/0353 - Junior doctors remuneration for days on strike/will be on strike
-
FOI/2023/0352 - Data security training, data breach reporting, security budgets
-
FOI/2023/0345 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI201730 Cancelled cancer operations
-
FOI/2023/0344 - Number of neonatal and stillbirth deaths since January 2013
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2023/0342 - Self-administration of medication policies
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology